**Exhibit      10.1**

**Alliance      Agreement**

----

**THIS      ALLIANCE AGREEMENT**      is made      on 11 October 2006

**PARTIES**

**ELIXIR      GROUP LIMITED**

**Elixir**

**VENDINGDATA      CORPORATION**

**VDC**

**JIM      CRABBE**

**Jim      Crabbe**

**MARK      NEWBURG**

**Mark      Newburg**

**BACKGROUND**

| A | Elixir                agrees that VDC can join the Asian gaming technology alliance established                by Elixir. |
|---|---------------------------------------------------------------------------------------------------------------------------|

| B | Contemporaneously                with the execution of this Agreement, Elixir and VDC will enter or                have                entered into such definitive agreements with a view to giving effect                to                the VDC Equity Issue and the Exclusive Distribution Arrangement and                during                the Evaluation Period the parties will continue to work to complete                the                Engineering and Manufacturing Alliance and the Elixir Equity Acquisition. |
|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**AGREED      TERMS**

| **1** | **Definitions                and interpretation** |
|-------|---------------------------------------------------|

| **1.1** | **Definitions** |
|---------|-----------------|

**Agreement**

*****          Confidential Treatment Requested**

----

**Asia      Representative Agreement**

**Authorised      Representative**

|   | “**Asia**”                means all countries in the generally accepted Asian region, including                Cambodia, China, Goa, Guam, India, Japan, Kazakhstan, Korea, Laos,                Macau,                Malaysia, Myanmar, Mongolia, Nepal, Philippines, Saipan, Singapore,                Russia, Sri Lanka, Tinian Islands, Taiwan, Thailand, Vietnam, provided                that each of the forgoing are legal gaming jurisdictions at such                time, any                cruise ship registered in or operates principally out of any of these                jurisdictions (assuming that they are legal at the time) and all                other                gaming jurisdictions in the generally accepted Asian region that                subsequently become legal. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | “**Change                of Control**”                means with respect to either Elixir or VDC, and shall be deemed to                occur                upon the happening of, any one of the                following: |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | The                acquisition, directly or indirectly, in a single transaction or a                series                of related transactions by any person or group of related persons                resulting in the beneficial ownership of 50% or more of the combined                voting power of the outstanding voting securities of the party or,                in the                case of Elixir, any parent corporation; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | The                consummation of a reorganization, merger or consolidation or sale                of                substantially all of the assets of the party or, in the case of Elixir,                any of its parent corporation (other than any such reorganization,                merger,                consolidation or sale of assets that relates to, for the purposes                of or                pursuant to (i) in the case of Elixir, any initial public offering                of                Elixir or its parent corporation and/or the Elixir Equity Acquisition;                and                (ii) in the case of VDC, the VDC Equity Issue and/or the Engineering                and                Manufacturing Alliance), including, without limitation, a corporation                which as a result of such transaction owns the party or all or                substantially all of the party’s assets either directly or through one or                more subsidiaries. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**Claim**

**Commencement      Date**

**Elixir      Equity Acquisition**

**Engineering      and Manufacturing Alliance**

|   | (a) | Elixir                integrating its research and development centre with VDC’s engineering                division in Zhuhai the People’s Republic of China; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | the                acquisition by Elixir of a direct equity interest in a special purpose                entity formed by VDC to hold the manufacturing facility of VDC located                in                Zhuhai, the People’s Republic of China; and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | the                manufacturing by VDC of Elixir’s product                requirements. |
|--------|-----|------------------------------------------------------------------------------------------------|

*****          Confidential Treatment Requested**

----

**Evaluation      Period**

|   | (a) | the                date of termination of this Agreement pursuant to clause 8;                and |
|--------|-----|---------------------------------------------------------------------------------------------------|

|   | (b) | 30                September 2007 or such later date as may be agreed by the parties                in                writing. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------|

**Event      of Default**

|   | (a) | a                party breaching any material provision of this Agreement or any of                the                agreements referred to in Section 2 (unless such breach is due to                fault on                the part of the other party or its affiliates) fails to remedy the                breach                within 30 days after receiving written notice of breach from the                other                party describing in reasonable detail the nature of the beach, unless                the                breach is incapable of remedy in which case the Event of Default                shall                occur immediately upon delivery of written notice by the non-breaching                party; |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | an                Insolvency Event occurring in relation to a                party. |
|--------|-----|-------------------------------------------------------------------------------------|

**Exclusive      Distribution Arrangement**

**Global      Alliance Arrangement**

**Global      Alliance Offer” **

**Insolvency      Event**

|   | (a) | the                person becomes insolvent, states that it is insolvent or is presumed                to be                insolvent under any applicable law; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | the                person is wound up, dissolved or declared                bankrupt; |
|--------|-----|---------------------------------------------------------------------------------------|

|   | (c) | the                person becomes an insolvent under administration under any applicable                law; |
|--------|-----|--------------------------------------------------------------------------------------------------------------|

|   | (d) | a                liquidator, provisional liquidator, controller, administrator, trustee                for                creditors, trustee in bankruptcy or other similar person is appointed                to,                or takes possession or control of, any or all of the person’s assets or                undertaking; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (e) | the                person enters into or becomes subject                to: |
|--------|-----|-----------------------------------------------------------------------------|

|  | (i) | any                assignment for the benefit of one or more of its creditors;                or |
|--|-----|--------------------------------------------------------------------------------------------------|

|  | (ii) | any                re-organisation, moratorium, deed of company arrangement or other                administration involving one or more of its                creditors; |
|--|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (f) | an                application or order is made (and, in the case of an application,                it is                not stayed, withdrawn or dismissed within 30 days), resolution passed,                proposal put forward, or any other action taken which is preparatory                to or                could result in any of (b),                (c),                (d)                or                (e)                above; or |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (g) | the                person suspends payment of its debts without any lawful reason, ceases                or                threatens to cease to carry on all or a material part of its business                or                becomes unable to pays its debts when they fall                due. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**Melco**

*****          Confidential Treatment Requested**

----

**Melco      PBL Joint Venture**

**New      Products**

**Parties**
**parties**
**Party**
**party**

**Products**

**Share      Placement Shares**

**Shuffle      Master**

**VDC      Equity Issue**

**Warrants**

| **1.2** | **Words                and expressions** |
|---------|------------------------------------------|

|   | (a) | the                singular includes the plural and vice                versa; |
|--------|-----|--------------------------------------------------------------------------------|

|   | (b) | words                denoting any gender include all                genders; |
|--------|-----|------------------------------------------------------------------------------|

|   | (c) | where                a word or phrase is defined, its other grammatical forms have a                corresponding meaning; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------|

|   | (d) | a                reference to a party, clause or paragraph is a reference to a party,                clause or paragraph of this                document; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (e) | headings                are for convenience and do not affect                interpretation; |
|--------|-----|----------------------------------------------------------------------------------------------|

|   | (f) | the                background or recitals to this document are adopted as and form part                of                this document; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

|   | (g) | a                reference to any document or agreement includes a reference to that                document or agreement as amended, novated, supplemented, varied or                replaced from time to time; |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (h) | a                reference to a time is a reference to local time of the party receiving                notice hereunder; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------|

|   | (i) | a                reference to a party includes its executors, administrators, successors,                substitutes (including persons taking by novation) and permitted                assigns; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (j) | a                reference to writing includes any method of representing words, figures                or                symbols in a permanent and visible                form; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

*****          Confidential Treatment Requested**

----

|   | (k) | words                and expressions denoting natural persons include bodies corporate,                partnerships, associations, firms, governments and governmental                authorities and agencies and vice                versa; |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (l) | no                rule of construction applies to the disadvantage of a party because                that                party was responsible for the preparation of this document or any                part of                it; and |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (m) | the                words “including”, “for example”, “such as” or other similar expressions                (in any form) are not words of                limitation. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **2** | **Contemporaneous                Agreements** |
|-------|-----------------------------------------------|

|   | (a) | the                Securities Purchase Agreement, the Common Stock Purchase Warrant                Agreement                and the Registration Rights Agreement and any other written documents                considered necessary to give effect to the VDC Equity Issue;                and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | an                amendment to the Sales Representative Agreement (the “Amended and Restated                Sales Representative Agreement”), which amendment agreement will give                effect to the Exclusive Distribution                Arrangement. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **3** | **Engineering                and Manufacturing Alliance** |
|-------|-----------------------------------------------------------|

| **3.1** | **Negotiation                of Engineering and Manufacturing                Alliance** |
|---------|-----------------------------------------------------------------------------------------|

| **3.2** | **Provisions                of Engineering                and Manufacturing Alliance** |
|---------|----------------------------------------------------------------------------------------|

|   | (a) | Elixir                will integrate its research and development centre (“**R&D                Centre**”)                with VDC’s engineering division in Zhuhai, the People’s Republic of China.                This integration will not involve the transfer of either party’s                intellectual property rights to the other or provide VDC with any                ownership rights in the R&D Centre or Elixir with any ownership rights                in VDC’s engineering division in                Zhuhai; |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | once                Elixir is satisfied that VDC has the capacity to produce sufficient                quantities of Elixir’s products at the agreed prices and consistently of                an acceptable quality, then VDC will manufacture all of Elixir’s product                requirements from its China manufacturing facility upon such terms                to be                agreed; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | Elixir                and VDC will negotiate in good faith the terms on which Elixir will                acquire a direct equity interest in a special purpose entity formed                by VDC                to hold the China manufacturing facility on terms mutually acceptable                to                Elixir and VDC, subject to regulatory approval and subject also to                there                being no regulatory impediment in respect to Elixir’s investment in VDC at                that time. It is currently envisaged that the amount invested by                Elixir to                acquire a direct equity interest in a special purpose entity formed                by VDC                may approximate US$1 million, (representing the outstanding capital                infusion commitment given to the local Chinese authority in respect                to the                China manufacturing facility), but that any such investment will                be                subject to finalisation of all relevant agreements and completion                of a                valuation that is satisfactory to both                parties. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

*****          Confidential Treatment Requested**

----

| **4** | **Elixir                Equity****Acquisition** |
|-------|-------------------------------------------------|

| **4.1** | **Development                of the Elixir Equity****Acquisition**** ** |
|---------|------------------------------------------------------------------------------|

|   | (a) | regulatory                and other legal considerations; |
|--------|-----|-----------------------------------------------------------|

|   | (b) | the                changes in operating markets; |
|--------|-----|--------------------------------------------------|

|   | (c) | the                changes in financial markets; and |
|--------|-----|------------------------------------------------------|

|   | (d) | interests                of key stakeholders and alliance                partners. |
|--------|-----|------------------------------------------------------------------------------------|

| **4.2** | **Board                and Shareholder Approval** |
|---------|---------------------------------------------------|

|   | (a) | shall                be subject to the approval of VDC shareholders, if required by law;                and |
|--------|-----|-------------------------------------------------------------------------------------------------------------|

|   | (b) | may                be subject to the approval of Melco’s shareholders pursuant to the Hong                Kong stock exchange listing rules. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------|

| **5** | **License                of Elixir Brand** |
|-------|--------------------------------------------|

|   | (a) | VDC                intends to rename itself Elixir Gaming Technologies Incorporated,                which                name will be owned by Elixir and in this respect, subject to the                approval                of Elixir’s board, Elixir intends to grant a license to VDC for use of the                trade name “Elixir” as soon as practicable after the Commencement Date, on                a royalty free, non-exclusive and non-transferable basis and otherwise                on                terms acceptable to both parties, which licence will come into effect                upon                such time to be agreed by the parties and will                be terminated forthwith in the event there is any enforcement action                brought against VDC by any regulatory body. and during that time                VDC will                transition to a new name and, at the end of that 90 day period, VDC                will                cease to use the Elixir name. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | Subject                to the grant of the license, VDC will not be permitted to use the“Elixir”                name in Asia as a product brand name to directly promote in Asia                any                product that Elixir does not distribute at that time; provided, however,                this restriction shall not otherwise prohibit VDC from conducting                business                in Asia under the corporate name “Elixir Gaming Technologies                Incorporated”. VDC, in connection with the use of the “Elixir” name, will                comply with all guidelines issued by Elixir in the license and as                Elixir                may issue from time to time regarding the use by VDC of the “Elixir” name.                Any new guideline or change to an existing guideline included in                the                original license that interferes in a material way with any then                current                use by VDC of the “Elixir” name in any material way will require the                consent of VDC, which consent will not be unreasonably                withheld. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | Other                than the immediate termination of the license granted by Elixir pursuant                to clause 5(a) in the event of any enforcement action brought against                VDC                by any regulatory authority as mentioned in clause 5(a), If this                Agreement                is terminated or the Amended and Restated Sales Representative Agreement                comes to an end for any reason whatsoever, Elixir may also terminate                the                licence by 90 days’ written notice and during that time VDC will                transition to a new name and, at the end of that 90 day period, VDC                will                cease to use the Elixir name. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

*****          Confidential Treatment Requested**

----

|   | (d) | During                the term of the license, Elixir will release and indemnify VDC from                and                against all Claims that VDC’s use of the name “Elixir Gaming Technologies                Incorporated” infringes the rights of another where the basis of the Claim                is attributable to an action or actions by Elixir subsequent to the                Commencement Date. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **6** | **Shareholder                approvals** |
|-------|------------------------------------------|

| **7** | **Restraints**** ** |
|-------|--------------------------|

| **7.1** | **Elixir                restraint** |
|---------|-------------------------------------|

|   | (a) | sell                any material portion of the business or material assets of Elixir                outside                of the ordinary course of business without making an Elixir Sale                of                Business Offer to VDC pursuant to clause 7.2;                or |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | sell                any capital shares of Elixir without making a Share Offer to VDC                pursuant                to clause 7.3. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------|

| **7.2** | **Elixir                Sale of Business Offer**** ** |
|---------|------------------------------------------------------------|

**Elixir      Sale of Business Offer**

| **7.3** | **Offer                to float business** |
|---------|--------------------------------------------|

**Share      Offer**

*****          Confidential Treatment Requested**

----

| **7.4** | **VDC                restraint** |
|---------|----------------------------------|

|   | (a) | compete                with Elixir in Asia in the shufflers, deck checking and verification                businesses; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------|

|   | (b) | take                any other action as would or could potentially cause a breach of                Elixir’s                legal obligations to Shuffle Master under the Asia Representative                Agreement; |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | compete                with Elixir in Asia in respect of any other business; |
|--------|-----|------------------------------------------------------------------------------|

|   | (d) | VDC                will not form a strategic alliance with any competitor of Elixir                with                respect to Asia or that is inconsistent with any Global Alliance                Arrangement; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (e) | VDC                will not dispose of any of its material portion of its business or                material assets outside of the ordinary course of business without                making                a VDC Sale of Business Offer to Elixir pursuant to clause 7.5;                or |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (f) | VDC                will not solicit any proposal for the Change of Control of VDC (other                than                the VDC Equity Issue and the Elixir Equity Acquisition);                or |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (g) | solicit                or persuade any person or entity to do anything which VDC is not                permitted                to do pursuant to clauses (i) through (iv). |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **7.5** | **VDC                Sale of Business Offer** |
|---------|-----------------------------------------------|

**VDC      Sale of Business Offer**

| **7.6** | ******* |
|---------|---------|

| **7.7** | **Limitation                on Global Alliance****Arrangements** |
|---------|------------------------------------------------------------------|

**Relevant      Party**

*****          Confidential Treatment Requested**

----

| **7.8** | **Global                Alliance Offer** |
|---------|------------------------------------------|

**Global      Alliance Offer**

| **7.9** | **Exceptions** |
|---------|----------------|

|   | (a) | the                directors of a party having breached their fiduciary duties;                or |
|--------|-----|---------------------------------------------------------------------------------------------------|

|   | (b) | the                infringement of any legislation, rule or regulation or breach of                any                contractual obligation that exists as at the date hereof by a party, |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **8** | **Termination** |
|-------|-----------------|

| **8.1** | **Termination                with immediate effect** |
|---------|------------------------------------------------------|

| **8.2** | **Effect                of termination** |
|---------|------------------------------------------|

| **9** | **Confidentiality** |
|-------|---------------------|

|   | (a) | The                parties acknowledge and agree that all negotiations and discussions                between them in respect of the Engineering and Manufacturing Alliance,                and                the Elixir Equity Acquisition and the implementation of the Engineering                and Manufacturing Alliance and the Elixir Equity Acquisition are                confidential and are governed by the Confidentiality Deed entered                into                between VDC and Elixir on 21 April 2006, but subject to the ***                . |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | Any                public announcement of the terms of this Agreement issued by a party                pursuant to any laws, rules and/or regulations must be in a form                approved                by the other party (provided that such approval shall not be unreasonably                withheld and in particular, regarding the disclosure of any such                information that may be specifically required by applicable laws,                rules or                regulations). |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | Unless                required by law, regulation or gaming authority, each party agrees                that it                will not issue any news release, public announcement (other than                those                public announcements referred to in clause 9(b) above), or                advertisement relating to this Agreement, its subject matter or any                transactions as contemplated hereunder, nor will it otherwise publicise                this Agreement, its subject matter or any transactions as contemplated                hereunder, without first obtaining the written approval of both Elixir                and                VDC. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

*****          Confidential Treatment Requested**

----

| **10** | **Notices** |
|--------|-------------|

| **10.1** | **Method** |
|----------|------------|

**Notices**

|   | (a) | in                writing; |
|--------|-----|----------------------------|

|   | (b) | signed                by the party giving notice or a person duly authorised by that                party; |
|--------|-----|------------------------------------------------------------------------------------------------------------|

|   | (c) | directed                to the recipient's address (as specified in clause 10.3 or as varied                by any notice duly given pursuant to clause 10.30.3);                and |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d) | hand                delivered, sent by prepaid post or transmitted by facsimile to that                address. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------|

| **10.2** | **Receipt** |
|----------|-------------|

|   | (a) | if                hand delivered at or before 4.30 pm local time on a business day, on                delivery, otherwise at 9.30 am local time on the next business                day; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | if                sent by prepaid post: |
|--------|-----|-----------------------------------------|

|   | (i) | within                the country in which the recipient is located, on the second business                day                after the date of posting; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (ii) | to                or from a place outside the country from which the party giving notice                is                located, on the seventh business day after the date of posting;                or |
|--------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | if                transmitted by facsimile at or before 4.30 pm local time on a                business day, at the time recorded on the transmission report indicating                successful transmission of the entire notice, otherwise at 9.30 am                local time on the next business                day. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **10.3** | **Address                of parties** |
|----------|---------------------------------------|

| Party:     |   | Elixir                                                                                                   |
|------------|--------|----------------------------------------------------------------------------------------------------------|
| Attention: |   | Gordon                  Yuen                                                                             |
| Copy:      |   | Melco                  International Development Limited                                                 |
| Attention: |   | Samuel                  Tsang                                                                            |
| Address:   |   | Penthouse,                  38/F, The Centrium, 60 Wyndham Street, Central, Hong                  Kong   |
| Facsimile: |   | (852)                  3162 3579                                                                         |
|       |   |                                                                                                     |
| Party:     |   | VDC                                                                                                      |
| Attention: |   | Mark                  R. Newburg                                                                         |
| Address:   |   | 6830                  Spencer Street, Las Vegas, Nevada 89119, United States of                  America |
| Facsimile: |   | (702)                  617 4737                                                                          |

*****            Confidential Treatment Requested**

----

| Party:     |   | Jim                  Crabbe                                                                              |
|------------|--------|----------------------------------------------------------------------------------------------------------|
| Address:   |   | 6830                  Spencer Street, Las Vegas, Nevada 89119, United States of                  America |
| Facsimile: |   | (702)                  617 4737                                                                          |
|       |   |                                                                                                     |
| Party:     |   | Mark                  Newburg                                                                            |
| Address:   |   | 6830                  Spencer Street, Las Vegas, Nevada 89119, United States of                  America |
| Facsimile: |   | (702)                  617 4737                                                                          |

| **11** | **General** |
|--------|-------------|

| **11.1** | **Entire                agreement** |
|----------|-------------------------------------|

| **11.2** | **Paramountcy                of document** |
|----------|--------------------------------------------|

| **11.3** | **No                merger** |
|----------|------------------------------|

| **11.4** | **Attorneys** |
|----------|---------------|

| **11.5** | **Amendment** |
|----------|---------------|

| **11.6** | **Assignment** |
|----------|----------------|

| **11.7** | **Successors                and Assigns** |
|----------|-------------------------------------------|

*****          Confidential Treatment Requested**

----

| **11.8** | **Severability** |
|----------|------------------|

| **11.9** | **Waiver** |
|----------|------------|

|   | (a) | must                be in writing signed by the party entitled to the benefit of that                power or                right; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | is                effective only to the extent set out in that written                waiver. |
|--------|-----|-----------------------------------------------------------------------------------------------|

| **11.10** | **Rights,                remedies additional** |
|-----------|------------------------------------------------|

| **11.11** | **Costs** |
|-----------|-----------|

| **11.12** | **Counterparts** |
|-----------|------------------|

| **11.13** | **Governing                law and jurisdiction** |
|-----------|---------------------------------------------------|

*****          Confidential Treatment Requested**

----

**EXECUTED**
**AGREEMENT**

| **EXECUTED**                by                **ELIXIR                GROUP LIMITED**by: | ))     |                                 |
|------------------------------------------------------------------------------------------|--------|--------------------------------------|
|                                                                                     |   |                                 |
|                                                                                     |   |                                 |
|                                                                                     |   | */s/                Leong Van Tak*   |
|                                                                                     |   | Signature                of director |
|                                                                                     |   |                                 |
|                                                                                     |   |                                 |
|                                                                                     |   | Leong                Van Tak         |
|                                                                                     |   | Name                of director      |

| **EXECUTED**                by                **VENDINGDATA****CORPORATION**                by: | ))     |                                                    |
|-------------------------------------------------------------------------------------------------|--------|---------------------------------------------------------|
|                                                                                            |   |                                                    |
|                                                                                            |   |                                                    |
|                                                                                            |   | */s/                Mark Newburg*                       |
|                                                                                            |   | Signature                of Officer                     |
|                                                                                            |   |                                                    |
|                                                                                            |   |                                                    |
|                                                                                            |   | Mark                R. Newburg, Chief Executive Officer |
|                                                                                            |   | Name                of director                         |

| **SIGNED**                by                **JIM                CRABBE**                in                the presence of | ))     |                            |
|----------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------|
|                                                                                                                       |   |                            |
|                                                                                                                       |   |                            |
| */s/                Irene Kaus*                                                                                            |   | */s/                Jim Crabbe* |
| Signature                of witness                                                                                        |   | Jim                Crabbe       |
|                                                                                                                       |   |                            |
|                                                                                                                       |   |                            |
| Irene                Kaus                                                                                                  |   |                            |
| Name                of witness (print)                                                                                     |   |                            |

| **SIGNED**                by                **MARK                NEWBURG**                in                the presence                of | ))     |                              |
|---------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------|
|                                                                                                                                        |   |                              |
|                                                                                                                                        |   |                              |
| */s/                Donna Vido*                                                                                                             |   | */s/                Mark Newburg* |
| Signature                of witness                                                                                                         |   | Mark                Newburg       |
|                                                                                                                                        |   |                              |
|                                                                                                                                        |   |                              |
| Dona                Vido                                                                                                                    |   |                              |
| Name                of witness (print)                                                                                                      |   |                              |

*****          Confidential Treatment Requested**

----